Literature DB >> 27819380

7th Brazilian Guideline of Arterial Hypertension: Chapter 1 - Concept, Epidemiology and Primary Prevention

Mvb Malachias, F L Plavnik, C A Machado, D Malta, L C N Scala, S Fuchs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27819380      PMCID: PMC5319472          DOI: 10.5935/abc.20160151

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.

Concept

Arterial hypertension (AH) is a multifactorial clinical condition characterized by sustained elevation of blood pressure (BP) levels ≥ 140 and/or 90 mm Hg. It is often associated with metabolic disorders, functional and/or structural changes in target organs, being worsened by the presence of other risk factors (RF), such as dyslipidemia, abdominal obesity, glucose intolerance and diabetes mellitus (DM).[1,2] It is independently associated with events such as sudden death, stroke, acute myocardial infarction (AMI), heart failure (HF), peripheral arterial disease (PAD) and fatal and non-fatal chronic kidney disease (CKD).[1-4]

Medical and social impact of arterial hypertension

North American data from 2015 revealed the presence of AH in 69% of patients on their first episode of AMI, in 77% of those with stroke, in 75% of those with HF and in 60% of those with PAD.[5] Arterial hypertension accounts for 45% of the cardiac deaths and for 51% of the deaths due to stroke.[6]

Arterial hypertension and cardiovascular disease in Brazil

In Brazil, AH affects 32.5% (36 million) of the adults, over 60% of the elderly, contributing direct or indirectly to 50% of the deaths due to cardiovascular disease (CVD).[7] Along with DM, its complications (cardiac, renal and stroke) have high impact on loss of work productivity and on family income, estimated as US$ 4.18 billion from 2006 to 2015.[8] In 2013 there were 1,138,670 deaths, 339,672 of which (29.8%) due to CVD, the major cause of death in Brazil (Figure 1).
Figure 1

Mortality rate in Brazil due to cardiovascular diseases (CVD) and distribution according to cause in 2013. IHD: ischemic heart disease; CbVD: cerebrovascular disease; HD: hypertensive disease; CHF: congestive heart failure.

Mortality rate in Brazil due to cardiovascular diseases (CVD) and distribution according to cause in 2013. IHD: ischemic heart disease; CbVD: cerebrovascular disease; HD: hypertensive disease; CHF: congestive heart failure. The mortality rates have decreased over the years, except for the hypertensive diseases (HD), which increased from 2002 to 2009, showing a reduction trend since 2010. The HD rates in that period ranged from 39/100,000 inhabitants (2000) to 42/100,000 inhabitants. Ischemic heart diseases (IHD) dropped from 120.4/100,000 inhabitants (2000) to 92/100,000 inhabitants (2013), cerebrovascular diseases (CbVD), from 137.7/100,000 inhabitants (2000) to 89/100,000 inhabitants (2013), and congestive HF (CHF), from 47.7/100,000 inhabitants (2000) to 24.3/100,000 inhabitants (2013)[9] (Figure 2).
Figure 2

Mortality rate in Brazil due to CVD from 2000 to 2013. Source: Information System on Mortality. Health Surveillance Secretariat, Brazilian Ministry of Health.

Mortality rate in Brazil due to CVD from 2000 to 2013. Source: Information System on Mortality. Health Surveillance Secretariat, Brazilian Ministry of Health. In addition, CVD account for the high frequency of hospitalizations, with high socioeconomic costs. Data from the Hospital Information System of the Brazilian Unified Public Health System point to a significant reduction in the hospitalization trend due to AH, from 98.1/100,000 inhabitants (2000) to 44.2/100,000 inhabitants (2013). Historical hospitalization rates due to CVD by region are shown in Figure 3, with a reduction for HD and stability or reduction trend for stroke, despite the increase in hospitalizations due to IHD.
Figure 3

Hospitalization rate in Brazil per 100,000 inhabitants, per geopolitical region, from 2010 to 2012.

Hospitalization rate in Brazil per 100,000 inhabitants, per geopolitical region, from 2010 to 2012.

Prevalence of arterial hypertension

The prevalence of HA in Brazil varies according to the population studied and the assessment method (Table 1).
Table 1

Prevalence of AH according to different approaches

SourceBPnGeneral (%)MenWomen
Picon et al.[10]*Measured17,08528.7 (26.2-31.4)27.3 (22.5-32.8)27.7 (23.7-32.0)
Scala et al.[7]Measured 21.9-46.6--
VIGITEL, 2014**Self-reported via telephone40,85325.0  
PNS, 2013**Self-reported62,98621.418.121.0
PNS, 2014**Measured59,40222.325.319.5

BP: blood pressure.

Meta-analysis; studies from the 2000 decade.

Note: Self-declared hypertensives under treatment were not considered hypertensive in the VIGITEL and PNS surveys.

Prevalence of AH according to different approaches BP: blood pressure. Meta-analysis; studies from the 2000 decade. Note: Self-declared hypertensives under treatment were not considered hypertensive in the VIGITEL and PNS surveys. In the meta-analysis by Picon et al., the 40 cross-sectional and cohort studies included showed a reduction trend in AH prevalence in the last three decades, from 36.1% to 31.0%.[10] A study with 15,103 government employees from six Brazilian capitals has reported a 35.8% AH prevalence, with predominance of men (40.1% vs 32.2%).[11] Data from VIGITEL (2006 to 2014) indicate that the self-reported AH prevalence among individuals aged 18 years and over, living in the capitals, ranged from 23% to 25%, respectively, with no difference in the period assessed, not even regarding sex. The self-reported AH prevalence varied among adults according to age groups as follows: 18 - 29 years, 2.8%; 30 - 59 years, 20.6%; 60 - 64 years, 44.4%; 65 - 74 years, 52.7%; and ≥ 75 years, 55%. The Southeastern region showed the highest self-reported AH prevalence (23.3%), followed by the Southern (22.9%) and West-Central (21.2%) regions. The Northeastern and Northern regions had the lowest rates, 19.4% and 14.5%, respectively.[12] In 2014, the Brazilian National Health Survey (PNS) measured the BP of selected dwellers from drawn residences, using calibrated digital semi-automated devices. Three BP measurements were taken at two-minute intervals, considering the mean of the last two measurements, inserted in smartphone. The overall prevalence of BP ≥140/90 mm Hg was 22.3%, with predominance among men (25.3% vs 19.5%), ranging from 26.7% in Rio de Janeiro to 13.2% in Amazonas, with predominance in the urban area as compared to the rural one (21.7% vs 19.8%).

Knowledge, treatment and control

A review[7] has shown a wide variation of BP knowledge (22% to 77%), treatment (11.4% to 77.5%) and control (10.1% to 35.5%) rates, depending on the population studied (Table 2).
Table 2

Blood pressure knowledge, treatment and control in 14 Brazilian population-based studies published from 1995 to 2009.[7]

Author/year per geopolitical regionPlaceNumber of individualsKnowledgeTreatmentControl
Southern     
Fuchs et al. 1995Porto Alegre (RS)1,09142.311.435.5
Gus et al. 2004Rio Grande Sul1,06350.840.510.4
Oliveira e Nogueira, 2003Cianorte (PR)41163.229.920.9
Trindade, 1998Passo Fundo (RS)20682.253.320
Pereira et al. 2007Tubarão (SC)70755.650.010.1
Southeastern     
Freitas et al. 2001Catanduva (SP)6887761.827.6
Souza et al. 2003Campos dos Goytacazes (RJ)1,02929.977.535.2
Barreto et al. 2001Bambuí (MG)2,31476.662.927
Castro et al. 2007Formiga (MG)28585.367.314.7
Mill et al. 2004Vitória (ES)1,65627.0  
West-Central     
Jardim et al. 2007Goiânia (GO)1,73964.343.412.9
Cassanelli, 2005Cuiabá (MT)1,69968.368.516.6
Rosário et al. 2009Nobres (MT)1,00373.561.924.2
Souza et al. 2007Campo Grande (MS)89269.157.3-
Blood pressure knowledge, treatment and control in 14 Brazilian population-based studies published from 1995 to 2009.[7]

Prehypertension

Prehypertension (PH) is characterized by systolic BP (SBP) between 121 and 139 and/or diastolic BP (DBP) between 81 and 89 mm Hg.[13] The world prevalence of PH has ranged from 21% to 37,7% in population-based studies, except for Iran (52.1%) (Figure 4).[14]
Figure 4

Prevalence of prehypertension (PH).

Prevalence of prehypertension (PH). Prehypertension associates with a higher risk of developing AH[15,16] and cardiac abnormalities.[17] Approximately one third of the cardiovascular (CV) events attributed to BP elevation occur in individuals with PH.[18] Meta-analyses of the incidence of CVD, IHD and stroke in prehypertensive individuals have shown a higher risk among those with BP levels between 130 and 139 or 85 and 89 mm Hg than among those with BP levels between 120 and 129 or 80 and 84 mm Hg (Figure 5).[14]
Figure 5

Meta-analysis of the risk of the incidence of cardiovascular disease (CVD) in individuals with prehypertension (PH).

Meta-analysis of the risk of the incidence of cardiovascular disease (CVD) in individuals with prehypertension (PH). The clinical implication of that epidemiological evidence is that the BP of prehypertensive individuals should be monitored closely, because a significant proportion of them will develop AH and its complications.[2]

Risk factors for arterial hypertension

Age

There is a direct and linear association between aging and AH prevalence related to the increase: i) in life expectancy of the Brazilian population, currently 74.9 years; ii) in the elderly population ≥ 60 years in the past decade (2000 to 2010), from 6.7% to 10.8%.[19] A meta-analysis of studies performed in Brazil including 13,978 elderly has shown a 68% AH prevalence.[20]

Sex and ethnicity

The 2013 Brazilian National Health Survey (PNS) showed a self-reported AH prevalence statistically different between sexes, being higher among women (24.2%) and black individuals (24.2%) as compared to mixed-heritage adults (20.0%), but not white individuals (22.1%). The Corações do Brasil Study has reported the following distribution: native population, 11.1%; yellow population, 10%; mixed heritage/mulatto, 26.3%; white, 29.4% and black, 34.8%.[21] The ELSA-Brazil Study has shown the following prevalences: white, 30.3%; mixed heritage, 38.2%; and black, 49.3%.[11]

Overweight and obesity

In Brazil, the 2014 VIGITEL data revealed, between 2006 and 2014, an increase in the prevalence of overweight (BMI ≥ 25 kg/m2, 52.5% vs 43%. In that same period, obesity (BMI ≥ 30 kg/m2 increased from 11.9% to 17.9%, predominating among 35-to-64-year-old individuals and women (18.2% vs 17.9%), but remained stable from 2012 to 2014.

Salt intake

The excessive consumption of sodium, one of the major RF for AH, associates with CV and renal events.[22,23] In Brazil, data of the Survey on Family Income (POF), collect from 55,970 dwellings, have shown home availability of 4.7g of sodium/person/day (adjusted for the consumption of 2,000 kcal), exceeding more than twice the maximum recommended consumption (2 g/day), lower in the urban area of the Southeastern region, and higher in the rural area of the Northern region.[24] The impact of the sodium-rich diet estimated in the 2014 VIGITEL data showed that only 15.5% of the individuals interviewed acknowledged high or extremely high salt content in their meals.[12]

Alcohol intake

A chronic and high consumption of alcoholic beverages increases BP consistently. A meta-analysis of 2012, including 16 studies with 33,904 men and 19,372 women compared the consumption intensity between non-drinkers and drinkers.[25] For women, there was a protective effect with doses lower than 10g of alcohol/day, and risk for AH with a consumption of 30-40g of alcohol/day. For men, the increased risk for AH became consistent from 31g of alcohol/day onwards. The 2006-2013 VIGITEL data showed that abusive alcohol consumption - at least four doses for women, or at least five doses for men, of alcoholic beverages on the same occasion, within the past 30 days - is stable in the adult population, around 16.4% (24.2% for men and 9.7% for women). For both sexes, abusive alcohol consumption was more often among youngsters, and increased with schooling.[25]

Sedentary lifestyle

A population-based study in the city of Cuiabá, Mato Grosso State, (n = 1,298 adults ≥ 18 years) has revealed a 75.8% overall prevalence of sedentary lifestyle (33.6% during leisure time; 19.9% at work; 22.3% during both). A significant association of AH was observed with age, male sex, overweight, central adiposity, sedentary lifestyle during leisure time and work, less than 8 years of schooling, per capita income < 3 minimum wages.[26] Brazilian National Health Survey (PNS) data indicate that insufficiently active individuals (adults not practicing at least 150 minutes per week of physical activity including leisure, work and displacement time) represent 46.0% of the adults, the percentage being significantly higher among women (51.5%). The frequencies of insufficiently active individuals differed between age groups, mainly among the elderly (62.7%) and the adults with no formal education and those with incomplete elementary education (50.6%).[27]

Socioeconomic factors

Adults with lower schooling (no formal education or incomplete elementary education) have a higher prevalence of self-reported AH (31.1%). The proportion decreases among those with complete elementary education (16.7%), being 18.2% among those with complete higher education.[26] However, the ELSA Brazil Study, performed with employees of six Brazilian universities and university-affiliated hospitals with higher schooling, has shown a 35.8% AH prevalence, higher among men.[11]

Genetics

Brazilian studies assessing the impact of genetic polymorphisms in the quilombola population could not identify a more prevalent pattern, showing the strong impact of miscegenation, and hindering the identification of a genetic pattern for the elevation of BP levels.[28,29]

Strategies for the implementation of preventive measures

The strategies for preventing the development of AH comprise public policies for health in combination with action from the medical societies and communication media. They should be aimed at stimulating early diagnosis, continuous treatment, control of BP and associated RF, by use of lifestyle changes and/or regular use of medications.
  21 in total

1.  Incidence of hypertension in Porto Alegre, Brazil: a population-based study.

Authors:  L B Moreira; S C Fuchs; M Wiehe; M Gus; R S Moraes; F D Fuchs
Journal:  J Hum Hypertens       Date:  2007-06-21       Impact factor: 3.012

Review 2.  Dietary factors associated with hypertension.

Authors:  Dong Zhao; Yue Qi; Zheng Zheng; Ying Wang; Xiu-Ying Zhang; Hong-Juan Li; Hai-Hang Liu; Xiao-Ting Zhang; Jie Du; Jing Liu
Journal:  Nat Rev Cardiol       Date:  2011-07-05       Impact factor: 32.419

Review 3.  Prehypertension--prevalence, health risks, and management strategies.

Authors:  Brent M Egan; Sean Stevens-Fabry
Journal:  Nat Rev Cardiol       Date:  2015-02-17       Impact factor: 32.419

4.  Prehypertension is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study.

Authors:  Angela B S Santos; Deepak K Gupta; Natalie A Bello; Mauro Gori; Brian Claggett; Flavio D Fuchs; Amil M Shah; Josef Coresh; A Richey Sharrett; Susan Cheng; Scott D Solomon
Journal:  Am J Hypertens       Date:  2015-09-07       Impact factor: 2.689

5.  Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region.

Authors:  Hisatomi Arima; Yoshitaka Murakami; Tai Hing Lam; Hyeon Chang Kim; Hirotsugu Ueshima; Jean Woo; Il Suh; Xianghua Fang; Mark Woodward
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

6.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 8.  Prevalence of hypertension among elderly persons in urban Brazil: a systematic review with meta-analysis.

Authors:  Rafael V Picon; Flávio D Fuchs; Leila B Moreira; Sandra C Fuchs
Journal:  Am J Hypertens       Date:  2013-01-29       Impact factor: 2.689

9.  Multilocus family-based association analysis of seven candidate polymorphisms with essential hypertension in an african-derived semi-isolated brazilian population.

Authors:  L Kimura; C B Angeli; M T B M Auricchio; G R Fernandes; A C Pereira; J P Vicente; T V Pereira; R C Mingroni-Netto
Journal:  Int J Hypertens       Date:  2012-09-26       Impact factor: 2.420

Review 10.  Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis.

Authors:  Rafael V Picon; Flávio D Fuchs; Leila B Moreira; Glaube Riegel; Sandra C Fuchs
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more
  49 in total

1.  Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Vinícius Bocchino Seleme; Gustavo Lenci Marques; Antonio Eduardo Matoso Mendes; Inajara Rotta; Milena Pereira; Emilton Lima Júnior; Claudio L Pereira da Cunha
Journal:  Am J Cardiovasc Drugs       Date:  2021-03       Impact factor: 3.571

Review 2.  Potential Mechanisms Behind the Blood Pressure-Lowering Effect of Dynamic Resistance Training.

Authors:  Rafael Y Fecchio; Leandro C Brito; Tiago Peçanha; Cláudia Lúcia de Moraes Forjaz
Journal:  Curr Hypertens Rep       Date:  2021-06-21       Impact factor: 5.369

Review 3.  Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective.

Authors:  Paul K Whelton
Journal:  Can J Cardiol       Date:  2019-02-27       Impact factor: 5.223

4.  Rating of Perceived Exertion in Three-Minute Step Test in Children with Cystic Fibrosis.

Authors:  Amanda P Silva; Erika V Araujo; Igor P Machado; Livia F Alves; Marcos F DA Silva Mello; Pedro Henrique DE A Silva; Isabella R Dias; Viviane Soares
Journal:  Int J Exerc Sci       Date:  2021-04-01

5.  Recreational beach tennis reduces 24-h blood pressure in adults with hypertension: a randomized crossover trial.

Authors:  Leandro Carpes; Alexandre Jacobsen; Lucas Domingues; Nathalia Jung; Rodrigo Ferrari
Journal:  Eur J Appl Physiol       Date:  2021-02-15       Impact factor: 3.078

6.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

7.  Biomarkers assessment in patients with Chagas disease and systemic arterial hypertension.

Authors:  Anderson de Oliveira Vieira; Gabriel Antônio Nogueira Nascentes; Ana Carolina de Morais Oliveira; Dalmo Correia; Marlene Cabrine-Santos
Journal:  Parasitol Res       Date:  2020-11-11       Impact factor: 2.289

8.  Independent predictors of effective blood pressure control in patients with hypertension on drug treatment in Brazil.

Authors:  Francisco Flavio Costa Filho; Ari Timerman; Jose Francisco Kerr Saraiva; Carlos Costa Magalhaes; Ibraim Masciarelli F Pinto; Gustavo B F Oliveira; Antonio Cordeiro Mattos; Alvaro Avezum
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-23       Impact factor: 3.738

9.  Acute severe hypertension associated with acute gastroenteritis in children.

Authors:  Jennifer E Fishbein; Christine B Sethna; Pamela Singer; Laura Castellanos-Reyes
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-15       Impact factor: 3.738

Review 10.  Is resistance training alone an antihypertensive therapy? A meta-analysis.

Authors:  Odilon Abrahin; Renilson Moraes-Ferreira; Erik Artur Cortinhas-Alves; João Farias Guerreiro
Journal:  J Hum Hypertens       Date:  2021-07-28       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.